Induced cervical ripening with Mifepristone in first trimester abortion. A double-blind randomized biomechanical study.

Abstract:

:Mifepristone (RU 486; Roussel-Uclaf, Paris, France) is an antiprogesterone used for termination of very early pregnancy. The ripening effect of Mifepristone on the human pregnant cervix was studied in 42 healthy women from 7 to 11 weeks gestation. The women were randomly allocated to oral treatment of either 100 mg Mifepristone or placebo for 24 and 12 hours before vacuum aspiration. An objective method has been designed to measure the force necessary to step-wise dilate the cervix from 4 to 11 mm. Significant (p less than 0.05) changes in the stiffness of the cervix were demonstrated in patients treated with Mifepristone, reflecting ripeness. The treatment was simple and had no side effects.

journal_name

Contraception

journal_title

Contraception

authors

Rådestad A,Christensen NJ,Strömberg L

doi

10.1016/0010-7824(88)90102-3

subject

Has Abstract

pub_date

1988-09-01 00:00:00

pages

301-12

issue

3

eissn

0010-7824

issn

1879-0518

pii

0010-7824(88)90102-3

journal_volume

38

pub_type

临床试验,杂志文章,随机对照试验
  • Mifepristone-misoprostol versus misoprostol-alone regimen for medication abortion at ≥24 weeks' gestation.

    abstract:OBJECTIVE:To compare time from misoprostol initiation to fetal expulsion for mifepristone-misoprostol versus misoprostol-alone regimens of medication abortion performed at ≥24 weeks' gestation. STUDY DESIGN:We conducted a retrospective study of medication abortion performed at ≥24 weeks' gestation between May 2016 and...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2020.05.001

    authors: Wingo E,Raifman S,Landau C,Sella S,Grossman D

    更新日期:2020-08-01 00:00:00

  • One year quality of life measured with SEC-QoL in levonorgestrel 52 mg IUS users.

    abstract:OBJECTIVES:The present study aims to prospectively evaluate quality of life (QoL) of women using 52-mg levonorgestrel intrauterine system (LNG-IUS) for contraception determined through the Sociedad Española de Contracepción (Spanish contraception Society) (SEC)-QoL, a questionnaire specifically designed to assess the i...

    journal_title:Contraception

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.contraception.2015.12.014

    authors: Cristobal I,Lete LI,Viuda E,Perulero N,Arbat A,Canals I

    更新日期:2016-04-01 00:00:00

  • Effectiveness of the Yuzpe regimen of emergency contraception by cycle day of intercourse: implications for mechanism of action.

    abstract:OBJECTIVE:The purpose of this study was to provide evidence about the mechanism of action of the Yuzpe method of emergency contraception by examining effectiveness by cycle day of intercourse relative to ovulation. METHODS:Through a literature search, we identified eight studies that present the number of women treate...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(02)00486-9

    authors: Trussell J,Ellertson C,Dorflinger L

    更新日期:2003-03-01 00:00:00

  • Further studies on pituitary and ovarian function in women receiving hormonal contraception.

    abstract::Pituitary and ovarian function was evaluated in women receiving 3 combined oral contraceptive preparations. Basal levels of follicle stimulating hormone (FSH) and luteinizing hormone (LH) and gonadotropic responses to gonadotropic releasing hormone (GnRH) were studied in 36 healthy, regularly ovulating women in the ea...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(81)90089-5

    authors: Cohen BL,Katz M

    更新日期:1981-08-01 00:00:00

  • Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.

    abstract:OBJECTIVES:Combined oral contraceptives (COCs) decrease testosterone (T) levels. This study investigated restoration of T and other androgen concentrations during COC use by 'co-administration' of dehydroepiandrosterone (DHEA). STUDY DESIGN:In this randomized, double-blind, placebo-controlled study in 99 new COC start...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2014.11.002

    authors: Zimmerman Y,Foidart JM,Pintiaux A,Minon JM,Fauser BC,Cobey K,Coelingh Bennink HJ

    更新日期:2015-02-01 00:00:00

  • Ultrasonographic and endocrine evaluation of ovarian function among Norplant implants users with regular menses.

    abstract::With the objective of evaluating the ovulatory function among long-term Norplant implants users with regular menstrual cycles, we undertook this prospective study including 11 Norplant implants users and 11 control women who were not using hormonal methods of fertility control. Exposed and unexposed women had had at l...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0010-7824(96)00179-5

    authors: Alvarez F,Brache V,Faundes A,Tejada AS,Thevenin F

    更新日期:1996-11-01 00:00:00

  • Associations of mental illness and substance use disorders with prescription contraception use among women veterans.

    abstract:OBJECTIVE:To investigate whether mental illness and substance use disorder (SUD) are associated with having a prescription contraceptive method among women veterans. STUDY DESIGN:We conducted a retrospective analysis of National Veterans Administration (VA) administrative and clinical data for women veterans aged 18-4...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2014.02.028

    authors: Callegari LS,Zhao X,Nelson KM,Lehavot K,Bradley KA,Borrero S

    更新日期:2014-07-01 00:00:00

  • Interval iud insertion in parous women: a randomized multicentre comparative trial of the Lippes Loop D, TCu220c and the Copper 7.

    abstract::A multicentre randomized clinical trial of the TCu220C, Lippes Loop D and Copper 7 was undertaken in nine WHO Collaborating centres for Clinical Research in Human Reproduction. A total of 984, 992 and 994 devices, respectively, were inserted between 1976 and 1978. The subjects were followed for two years. At this time...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(82)90167-6

    authors:

    更新日期:1982-07-01 00:00:00

  • Do retroverted uteri adversely affect insertions and performance of IUDs?

    abstract::A large international multi-center IUD data set (N = 5520) coordinated by Family Health International was analysed to determine if the uterine position of a woman (anteverted, mid-positioned or retroverted) affects the ease of IUD insertion and if knowledge of uterine position would diminish insertion-related problems...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/0010-7824(90)90059-5

    authors: Chi IC,Farr G,Dominik R,Robinson N

    更新日期:1990-05-01 00:00:00

  • Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics.

    abstract:BACKGROUND:Cyclofem is a combined injectable contraceptive, containing medroxyprogesterone acetate (MPA) and estradiol cypionate. The objective was to characterize the steady-state pharmacokinetics (PK) using tandem liquid chromatography/mass spectrometry and compare these data to a previous PK study of this formulatio...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2012.11.010

    authors: Thurman A,Kimble T,Hall P,Schwartz JL,Archer DF

    更新日期:2013-06-01 00:00:00

  • Postabortal contraception with norethisterone enanthate injections.

    abstract::Intramuscular injection of 200 mg norethisterone enanthate (NET-EN) was given to five women on the day of first trimester abortion. The injection was repeated twice at eight-week intervals, and thereafter at twelve-week intervals for one year. Plasma samples were collected for FSH, LH/hCG, estradiol, progesterone and ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(83)90020-3

    authors: Lähteenmäki P,Toivonen J,Lähteenmäki PL

    更新日期:1983-06-01 00:00:00

  • Conditions in rural Nepal for which depot-medroxyprogesterone acetate initiation is not recommended: implications for community-based service delivery.

    abstract::The presence of medical conditions that might affect the use of depot-medroxyprogesterone acetate (DMPA) as a contraceptive method was assessed in a rural district in Nepal. A general health survey was conducted in nonpregnant and noncontracepting women aged 15-44 years to determine the presence of any health problems...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(99)00056-6

    authors: Rai C,Thapa S,Day J,Bhattarai L,McMullen S,Jha R,Shrestha S,Bastola S,Rivera R

    更新日期:1999-07-01 00:00:00

  • A 4-year follow-up study of women with Norplant-2 contraceptive implants.

    abstract::One-hundred-thirty of 178 women who received Norplant-2 implants were followed prospectively for 4 years. Menstrual disorders were the most common reason for discontinuation. Only one patient conceived, for a failure rate of 0.6%. ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(01)00265-7

    authors: Qin LH,Goldberg JM,Hao G

    更新日期:2001-11-01 00:00:00

  • Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease.

    abstract:BACKGROUND:Women with cardiac disease have need for effective long-lasting reversible contraception. Women with cardiac disease are at increased risk for bacterial endocarditis. There is limited research regarding the use of intrauterine contraceptive devices (IUD) in women with cardiac disease. STUDY DESIGN:In a pros...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.contraception.2008.05.006

    authors: Suri V,Aggarwal N,Kaur R,Chaudhary N,Ray P,Grover A

    更新日期:2008-10-01 00:00:00

  • Bleeding patterns of adolescents using a combination contraceptive injection for 1 year.

    abstract:PURPOSE:This prospective observational study evaluated the bleeding patterns of adolescents receiving a monthly injectable contraceptive containing norethisterone enanthate 50 mg plus estradiol valerate 5 mg. MATERIALS AND METHODS:The study enrolled 73 volunteers aged between 14 and 19 years; of these patients, 38 (52...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2006.01.009

    authors: Bortolotti de Mello Jacobucci MS,Guazzelli CA,Barbieri M,Araújo FF,Moron AF

    更新日期:2006-06-01 00:00:00

  • Effects of gossypol on the kidney with special emphasis on potassium (K) excretion.

    abstract::The overall and renal toxicity of racemic gossypol acetic acid was assessed in 6 mongrel dogs. Oral racemic gossypol acetic acid was given orally at doses increasing from 10 to 40 mg/d for a total of 6 weeks in 3 female dogs and from 40 to 80 mg/d for a total of 4 weeks in 3 male dogs. The animals were then sacrificed...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(88)90127-8

    authors: van Ypersele de Strihou C,Dieu JP,Marbaix E

    更新日期:1988-02-01 00:00:00

  • An educational intervention on drug interactions and contraceptive options for epilepsy patients: a pilot randomized controlled trial.

    abstract:OBJECTIVE:This pilot study investigates whether an educational handout could increase short-term information retention about drug interactions between antiepileptic drugs (AEDs) and hormonal contraceptives among female epilepsy patients of reproductive age. STUDY DESIGN:This is a pilot randomized controlled trial of a...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2015.07.008

    authors: Mody SK,Haunschild C,Farala JP,Honerkamp-Smith G,Hur V,Kansal L

    更新日期:2016-01-01 00:00:00

  • Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action.

    abstract::All intrauterine devices (IUDs) that have been tested experimentally or clinically induce a local inflammatory reaction of the endometrium whose cellular and humoral components are expressed in the tissue and the fluid filling the uterine cavity. Depending on the reproductive strategy of the species considered and the...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2007.01.020

    authors: Ortiz ME,Croxatto HB

    更新日期:2007-06-01 00:00:00

  • Interaction of anticonvulsants and oral contraceptives in epileptic adolescents.

    abstract::Oral contraceptives are in widespread use, and are commonly prescribed for contraception in patients taking other medications. An example of this is the concomitant use of oral contraceptives and anticonvulsants in epileptic patients. This combination creates a potential for drug interactions which may alter the effic...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(85)90062-9

    authors: Diamond MP,Greene JW,Thompson JM,VanHooydonk JE,Wentz AC

    更新日期:1985-06-01 00:00:00

  • Amenorrhea associated with contraception-an international study on acceptability.

    abstract::Surveys undertaken in the 1970s and 1980s suggested that amenorrhea was unacceptable to most women, especially in developing countries. More recent research suggests that increasing numbers of women in the developed world prefer to menstruate less often. In a questionnaire survey of 1001 women attending family-plannin...

    journal_title:Contraception

    pub_type: 杂志文章,多中心研究

    doi:10.1016/s0010-7824(02)00474-2

    authors: Glasier AF,Smith KB,van der Spuy ZM,Ho PC,Cheng L,Dada K,Wellings K,Baird DT

    更新日期:2003-01-01 00:00:00

  • Levels of contraceptive seroids in breast milk and plasma of lactating women.

    abstract::Levels of contraceptive steroids in breast milk and plasma of lactating women were investigated. 7 lactating women received 150 mg medroxyprogesterone acetate (MPA) 1 week after delivery. 5 women (lactating) took 350 mcg norethisterone (NET) and 2 took 150 mcg d-norgestrel (d-ng) + 30 mcg ethinyl estradiol. Milk an...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(77)90061-0

    authors: Saxena BN,Shrimanker K,Grudzinskas JG

    更新日期:1977-12-01 00:00:00

  • Oral contraceptives and family history of breast cancer.

    abstract:BACKGROUND:Questions remain regarding whether oral contraceptive (OC) use among women with a family history of breast cancer increases disease risk. STUDY DESIGN:We conducted a systematic review by searching MEDLINE and CENTRAL databases for evidence (in all languages) published in peer-reviewed journals from 1966 to ...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2009.04.010

    authors: Gaffield ME,Culwell KR,Ravi A

    更新日期:2009-10-01 00:00:00

  • Comparison of outcomes at 6 weeks following postpartum intrauterine contraceptive device insertions by doctors and nurses in India: a case-control study.

    abstract:OBJECTIVE:As part of a strategy to revitalize postpartum family planning services, Government of India revised its policy in 2013 to permit trained nurses and midwives to insert postpartum intrauterine contraceptive devices (PPIUCDs). This study compares two key outcomes of PPIUCD insertions--expulsion and infection--f...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2015.12.012

    authors: Yadav V,Balasubramaniam S,Das S,Srivastava A,Srivastava A,Kumar S,Sood B

    更新日期:2016-04-01 00:00:00

  • Biochemical studies with once-a-month contraceptive pill containing quinestrol-quingestanol acetate.

    abstract::Biochemical studies with a once-a-month contraceptive pill containing 2 mg quinestrol and 2.5 mg quingestanol acetate were undertaken during a period of 24 months. The 1st pill was given on the 2nd day of the menstrual cycle and the 2nd on the 22nd day of the same cycle; thereafter the pills were given every 28th day...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(75)90065-7

    authors: Donde UM,Virkar KD

    更新日期:1975-06-01 00:00:00

  • Inhibition of luteal phase progesterone levels in the rhesus monkey by epostane.

    abstract::This study examined the effect of epostane, a new antifertility drug, on normal and hCG-stimulated progesterone production during the luteal phase of the menstrual cycle in rhesus monkeys. When administered once each day for five days, epostane inhibited normal luteal phase progesterone levels in a dose-related fashio...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(85)90083-6

    authors: Snyder BW,Schane HP

    更新日期:1985-05-01 00:00:00

  • Menstrual patterns and progesterone circulating levels following different procedures of tubal occlusion.

    abstract::This study was undertaken to assess the effects of different tubal occlusion procedures on ovarian function. Three groups of subjects randomized to tubal occlusion by laparoscopy and Yoon ring (24 subjects), minilaparotomy and Yoon ring (19 subjects) and minilaparotomy and Pomeroy (22 subjects), and one separate contr...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(89)90003-6

    authors: Rivera R,Gaitan JR,Ruiz R,Hurley DP,Arenas M,Flores C,Hernandez AB

    更新日期:1989-08-01 00:00:00

  • Acceptability of levonorgestrel subdermal implants versus tubal ligation for long-term contraception in a rural population of Zimbabwe.

    abstract::This prospective cohort study of 257 rural Zimbabwean women was designed to compare patient satisfaction with levonorgestrel subdermal implants (Norplant and reg;) versus tubal ligation (TL) as a method of long-term contraception. Women were equally satisfied with both methods. At 1 year, 96% of Norplant users and 97%...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2004.05.004

    authors: Mitchel MJ,Thistle P

    更新日期:2004-12-01 00:00:00

  • Study of the effect of ulipristal acetate on human sperm ability to interact with tubal tissue and cumulus-oocyte-complexes.

    abstract:OBJECTIVE:Ulispristal acetate (UPA) is a selective progesterone receptor modulator widely used for emergency contraception (EC). The described main mechanism of action is by inhibiting or delaying ovulation; however, the postovulatory effects of the drug are still on debate. Therefore, the aim of this study was to dete...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2017.02.019

    authors: Zumoffen C,Gómez-Elías MD,Caille AM,Bahamondes L,Cuasnicú PS,Cohen DJ,Munuce MJ

    更新日期:2017-06-01 00:00:00

  • Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine system.

    abstract:OBJECTIVE:The aim of this study was to assess the presence of ovarian cysts in women using a new low-dose levonorgestrel-releasing intrauterine contraceptive system (LNG-IUS 13.5mg [total content]). STUDY DESIGN:A Phase 3 study assessed LNG-IUS 13.5mg use in healthy women with regular menstrual cycles who requested co...

    journal_title:Contraception

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.contraception.2015.01.021

    authors: Nahum GG,Kaunitz AM,Rosen K,Schmelter T,Lynen R

    更新日期:2015-05-01 00:00:00

  • Provision of medical abortion using telemedicine in Brazil.

    abstract:OBJECTIVE:To evaluate the need for and outcome of self-administered medical abortion with mifepristone and misoprostol in Brazil, provided through Women on Web, a global telemedicine abortion service. STUDY DESIGN:A retrospective case review of women from Brazil who contacted Women on Web in 2011. Information from the...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2013.11.005

    authors: Gomperts R,van der Vleuten K,Jelinska K,da Costa CV,Gemzell-Danielsson K,Kleiverda G

    更新日期:2014-02-01 00:00:00